The Health Policy Exchange
FEBRUARY 12, 2013
In contrast to the personality-driven path that Lyndon Johnson took to navigate legislative obstacles to Medicare and Medicaid, former management consultant Mitt Romney charted a decidedly different course to expanding health insurance when he became governor of Massachusetts in 2003. It was one thing to ask drivers to buy car insurance.
FDA Law Blog
JUNE 7, 2023
to transfer their patented pharmaceutical products to Medicare beneficiaries, for public use” at a government-dictated price that is a fraction of the drug’s value. Merck asks the Court to declare that the Negotiations Program is a taking without just compensation and to enjoin the government’s agreements under the Fifth Amendment.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog
JUNE 15, 2022
Kirschenbaum — In 2017, the Centers for Medicare & Medicaid Services (“CMS”) issued a final rule to significantly decrease the rate the government will reimburse 340B hospitals in 2018 for outpatient prescription drugs from average sales price (“ASP”) plus 6% to ASP minus 22.5%. By Faraz Siddiqui & Alan M. 52494 (Nov. citing 967 F.
FDA Law Blog
APRIL 23, 2021
129 (2003). FDA’s response to our 2003 article, authored by Eric M. 169 (2003). Background on the case can be found in earlier posts here , here , here , and here. We conclude that it does not. It did that by focusing on the text of the statute. Fleder, Can FDA Seek Restitution or Disgorgement ? , 58 Food and Drug L.J.
GeriPal
MAY 12, 2022
Raj faced in pain management: access to opioids, corruption, a system that doesn’t see addressing suffering as a priority. Prognosis communication and the subtle ways we may communicate it without intention. Social pain and loneliness. Community-based palliative care networks . Raj’s reflections on the state of palliative care in the US. Transcript.
FDA Law Blog
SEPTEMBER 6, 2021
Teva case, that the statutory provisions governing patent infringement, specifically induced infringement, do not address carve-outs. Teva received tentative approval in June 2003 and launched in 2007 after a blocking patent expired. The catch is, as we have learned from the GSK v. Teva decision changed everything.
Physician's Weekly
JUNE 12, 2025
In a 2005 article for Rolling Stone that was later retracted, Kennedy claimed government officials had buried data showing a link between vaccines and autism, The Wall Street Journal said. The final findings were published in 2003. It’s unclear if he has regained access. It added that “HHS will follow the science — wherever it leads.”
Expert insights. Personalized for you.
130 
Let's personalize your content